Korro Bio Inc.

NASDAQ: KRRO
Share price (3/28/25): $17.44
Market cap (3/28/25): $164 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Prospectus supplement for primary offering

Updated info for already-effective prospectus

Ownership Filter

Citadel Advisors LLC

Driehaus Capital Management LLC

Alliancebernstein L.P.

News Filter

Change in Directors, Officers or Compensation

Reports Full Year 2024 Financial Results and Provides Business Updates

Change in Directors, Officers or Compensation

Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC